Screener
USANA Health Sciences USNA Gross Profit
Discontinued — last reported Q1 '26
Gross Profit at other companies
Other financials
Where this comes from
Calculated from USANA Health Sciences’s reported figures.
The source filing: USANA Health Sciences’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:35 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000896264-26-000034
| Line item | Three months ended / April 4,2026 | Three months ended / March 29,2025 |
|---|---|---|
| Net sales | $250,218 | $249,539 |
| Cost of sales | 59,436 | 52,445 |
| Gross profit | 190,782 | 197,094 |
| Operating expenses: | ||
| Brand Partner incentives | 88,654 | 89,985 |
| Selling, general and administrative | 88,254 | 91,438 |
| Total operating expenses | 176,908 | 181,423 |
| Earnings from operations | 13,874 | 15,671 |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is USANA Health Sciences's gross profit?
- USANA Health Sciences (USNA) reported gross profit of $190.78M in Q1 2026.
- How has USANA Health Sciences's gross profit changed year-over-year?
- USANA Health Sciences's gross profit decreased by 3.2% year-over-year, from $197.09M to $190.78M.
- What is the long-term trend for USANA Health Sciences's gross profit?
- Over 3 years (2022 to 2025), USANA Health Sciences's gross profit has grown at a -3.4% compound annual growth rate (CAGR), from $804.71M to $724.41M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about USANA Health Sciences's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude